Table of Contents Author Guidelines Submit a Manuscript
Scientifica
Volume 2016, Article ID 5619358, 6 pages
http://dx.doi.org/10.1155/2016/5619358
Research Article

Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations

1Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63110, USA
2Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, MO 63110, USA
3Division of Hematology and Oncology, Saint Louis University School of Medicine, St. Louis, MO 63110, USA
4Department of Radiology, Saint Louis University School of Medicine, St. Louis, MO 63110, USA
5Department of General Surgery, Saint Louis University School of Medicine, St. Louis, MO 63110, USA

Received 3 December 2015; Accepted 23 February 2016

Academic Editor: Cosimo Sperti

Copyright © 2016 Elie Chahla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Raimondi, P. Maisonneuve, and A. B. Lowenfels, “Epidemiology of pancreatic cancer: an overview,” Nature Reviews Gastroenterology and Hepatology, vol. 6, no. 12, pp. 699–708, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman, and L. M. Matrisian, “Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States,” Cancer Research, vol. 74, no. 11, pp. 2913–2921, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Lim, M. W. Chien, and C. C. Earle, “Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients,” Annals of Surgery, vol. 237, no. 1, pp. 74–85, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Sun, H. Ma, G. Hong, H. Sun, and J. Wang, “Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010,” Scientific Reports, vol. 4, article 6747, 2014. View at Publisher · View at Google Scholar
  5. M. I. Canto, M. Goggins, R. H. Hruban et al., “Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study,” Clinical Gastroenterology and Hepatology, vol. 4, no. 6, pp. 665, 766–781, 2006. View at Google Scholar
  6. M. I. Canto, F. Harinck, R. H. Hruban et al., “International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer,” Gut, vol. 62, no. 3, pp. 339–347, 2013. View at Publisher · View at Google Scholar
  7. E. M. Stoffel, “Screening in GI cancers: the role of genetics,” Journal of Clinical Oncology, vol. 33, no. 16, pp. 1721–1728, 2015. View at Publisher · View at Google Scholar
  8. P. Lichtenstein, N. V. Holm, P. K. Verkasalo et al., “Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland,” The New England Journal of Medicine, vol. 343, no. 2, pp. 78–85, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. K. M. Murphy, K. A. Brune, C. Griffin et al., “Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%,” Cancer Research, vol. 62, no. 13, pp. 3789–3793, 2002. View at Google Scholar · View at Scopus
  10. S. A. Hahn, B. Greenhalf, I. Ellis et al., “BRCA2 germline mutations in familial pancreatic carcinoma,” Journal of the National Cancer Institute, vol. 95, no. 3, pp. 214–221, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. F. J. Couch, M. R. Johnson, K. G. Rabe et al., “The prevalence of BRCA2 mutations in familial pancreatic cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 16, no. 2, pp. 342–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. The Breast Cancer Linkage Consortium, “Cancer risks in BRCA2 mutation carriers: the breast cancer linkage consortium,” Journal of the National Cancer Institute, vol. 91, no. 15, pp. 1310–1316, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Thompson and D. F. Easton, “Cancer incidence in BRCA1 mutation carriers,” Journal of the National Cancer Institute, vol. 94, no. 18, pp. 1358–1365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Moran, C. O'Hara, S. Khan et al., “Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations,” Familial Cancer, vol. 11, no. 2, pp. 235–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. R. Ferrone, D. A. Levine, L. H. Tang et al., “BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma,” Journal of Clinical Oncology, vol. 27, no. 3, pp. 433–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Kim, B. Crawford, J. Ziegler, and M. S. Beattie, “Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations,” Familial Cancer, vol. 8, no. 2, pp. 153–158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. E. Becker, Y. G. Hernandez, H. Frucht, and A. L. Lucas, “Pancreatic ductal adenocarcinoma: risk factors, screening, and early detection,” World Journal of Gastroenterology, vol. 20, no. 32, pp. 11182–11198, 2014. View at Publisher · View at Google Scholar · View at Scopus